cytarabine has been researched along with vitamin k semiquinone radical in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisasue, M; Ishikawa, T; Nagashima, N; Neo, S; Nishimura, T; Tsuchiya, R; Yamada, T | 1 |
| Simmons, D; Yu, D; Zhao, Z | 1 |
2 other study(ies) available for cytarabine and vitamin k semiquinone radical
| Article | Year |
|---|---|
A dog with acute myelomonocytic leukemia.
Topics: Animals; Antineoplastic Agents; Cytarabine; Dog Diseases; Dogs; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Hematologic Tests; Leukemia, Myelomonocytic, Acute; Prednisolone; Vincristine; Vitamin K | 2008 |
Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Cardiovascular Diseases; Comorbidity; Cytarabine; Diabetes Mellitus, Type 2; England; Female; Hemorrhage; Humans; Incidence; Male; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vitamin K; Warfarin | 2020 |